
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9307164
[patent_doc_number] => 20140045838
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'KINASE INHIBITORS AND METHOD OF TREATING CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/935021
[patent_app_country] => US
[patent_app_date] => 2013-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 123708
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935021
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935021 | Kinase inhibitors and method of treating cancer | Jul 2, 2013 | Issued |
Array
(
[id] => 9307149
[patent_doc_number] => 20140045822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME'
[patent_app_type] => utility
[patent_app_number] => 13/935016
[patent_app_country] => US
[patent_app_date] => 2013-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 123720
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13935016
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/935016 | Kinase inhibitors and method of treating cancer with same | Jul 2, 2013 | Issued |
Array
(
[id] => 10311032
[patent_doc_number] => 20150196033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO'
[patent_app_type] => utility
[patent_app_number] => 14/409796
[patent_app_country] => US
[patent_app_date] => 2013-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48704
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409796
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/409796 | PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO | Jun 30, 2013 | Abandoned |
Array
(
[id] => 10191802
[patent_doc_number] => 09220695
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances'
[patent_app_type] => utility
[patent_app_number] => 14/408748
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 28038
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408748
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/408748 | Polyenolic zinc-binding agents (pezbins) actively promote inactivation of cancer stem cells and potentiate cytotoxic anti-tumor drug substances | Jun 27, 2013 | Issued |
Array
(
[id] => 9739807
[patent_doc_number] => 20140275527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases'
[patent_app_type] => utility
[patent_app_number] => 13/929062
[patent_app_country] => US
[patent_app_date] => 2013-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102142
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929062
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/929062 | Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases | Jun 26, 2013 | Abandoned |
Array
(
[id] => 10281581
[patent_doc_number] => 20150166578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'PYRROLIDINE DERIVATIVES AND THEIR USE AS COMPLEMENT PATHWAY MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/409882
[patent_app_country] => US
[patent_app_date] => 2013-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31635
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409882
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/409882 | Pyrrolidine derivatives and their use as complement pathway modulators | Jun 26, 2013 | Issued |
Array
(
[id] => 10306493
[patent_doc_number] => 20150191493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/413495
[patent_app_country] => US
[patent_app_date] => 2013-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 18244
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413495
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/413495 | NEW PROCESS FOR PREPARING ARYLBORANES BY ARYLATION OF ORGANOBORON COMPOUNDS | Jun 26, 2013 | Abandoned |
Array
(
[id] => 9122132
[patent_doc_number] => 20130289054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-31
[patent_title] => 'THIENOPYRIMIDINEDIONE DERIVATIVES AS TRPA1 MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/925975
[patent_app_country] => US
[patent_app_date] => 2013-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25383
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/925975 | Thienopyrimidinedione derivatives as TRPA1 modulators | Jun 24, 2013 | Issued |
Array
(
[id] => 11191508
[patent_doc_number] => 09422309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => '3-O-heteroaryl-ingenol'
[patent_app_type] => utility
[patent_app_number] => 14/409374
[patent_app_country] => US
[patent_app_date] => 2013-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26609
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409374
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/409374 | 3-O-heteroaryl-ingenol | Jun 20, 2013 | Issued |
Array
(
[id] => 9281593
[patent_doc_number] => 20140031561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'Crystalline Forms and Processes for Their Preparation'
[patent_app_type] => utility
[patent_app_number] => 13/922085
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 20987
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13922085
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/922085 | Crystalline forms and processes for their preparation | Jun 18, 2013 | Issued |
Array
(
[id] => 9295331
[patent_doc_number] => 20140038965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-06
[patent_title] => '5- AND 6-MEMBERED HETEROCYCLIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/919516
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30231
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13919516
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/919516 | 5- AND 6-MEMBERED HETEROCYCLIC COMPOUNDS | Jun 16, 2013 | Abandoned |
Array
(
[id] => 10374289
[patent_doc_number] => 20150259295
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/402128
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15193
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14402128
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/402128 | SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTS | Jun 16, 2013 | Abandoned |
Array
(
[id] => 9971250
[patent_doc_number] => 09018260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-28
[patent_title] => 'Indanesulfamide derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/370633
[patent_app_country] => US
[patent_app_date] => 2013-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23499
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370633
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/370633 | Indanesulfamide derivatives | Jun 16, 2013 | Issued |
Array
(
[id] => 9552486
[patent_doc_number] => 08759538
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-06-24
[patent_title] => 'Crystalline chemotherapeutic'
[patent_app_type] => utility
[patent_app_number] => 13/916891
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5794
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916891
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/916891 | Crystalline chemotherapeutic | Jun 12, 2013 | Issued |
Array
(
[id] => 10192917
[patent_doc_number] => 09221814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/403787
[patent_app_country] => US
[patent_app_date] => 2013-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31334
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403787
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403787 | Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereof | Jun 6, 2013 | Issued |
Array
(
[id] => 10288362
[patent_doc_number] => 20150173361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'PLANT DISEASE CONTROL COMPOSITION AND PLANT DISEASE CONTROL METHOD'
[patent_app_type] => utility
[patent_app_number] => 14/406953
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3067
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406953
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/406953 | Plant disease control composition and plant disease control method | Jun 5, 2013 | Issued |
Array
(
[id] => 11915336
[patent_doc_number] => 09783514
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Method for preparing methylated amines'
[patent_app_type] => utility
[patent_app_number] => 14/404865
[patent_app_country] => US
[patent_app_date] => 2013-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9431
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404865
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404865 | Method for preparing methylated amines | Jun 3, 2013 | Issued |
Array
(
[id] => 10354878
[patent_doc_number] => 20150239883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'NEW COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/404188
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57661
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404188
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404188 | Compounds | May 29, 2013 | Issued |
Array
(
[id] => 11766959
[patent_doc_number] => 09375477
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'Topical compositions of aqueous gel type in the form of a homogeneous suspension of an active principle of the retinoid class containing at least one hydrophobic silica'
[patent_app_type] => utility
[patent_app_number] => 14/404920
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 11704
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404920
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404920 | Topical compositions of aqueous gel type in the form of a homogeneous suspension of an active principle of the retinoid class containing at least one hydrophobic silica | May 29, 2013 | Issued |
Array
(
[id] => 11282627
[patent_doc_number] => 09498465
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-22
[patent_title] => 'Topical compositions in the form of a gel containing a particular solubilized retinoid'
[patent_app_type] => utility
[patent_app_number] => 14/404913
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6133
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404913
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404913 | Topical compositions in the form of a gel containing a particular solubilized retinoid | May 29, 2013 | Issued |